z-logo
Premium
Envisioning the Future of Nanotechnology Platforms for Biomedicine
Author(s) -
Cho NamJoon
Publication year - 2016
Publication title -
small
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.785
H-Index - 236
eISSN - 1613-6829
pISSN - 1613-6810
DOI - 10.1002/smll.201503951
Subject(s) - biomedicine , nanomedicine , nanotechnology , applications of nanotechnology , computer science , engineering , engineering ethics , materials science , nanoparticle , bioinformatics , biology
DOI: 10.1002/smll.201503951 Prof. N.-J. Cho School of Materials Science and Engineering Nanyang Technological University 50 Nanyang Avenue 639798 , Singapore E-mail: njcho@ntu.edu.sg Prof. N.-J. Cho Nanyang Institute of Technology in Health and Medicine Nanyang Technological University 50 Nanyang Drive 637553 , Singapore Prof. N.-J. Cho School of Chemical and Biomedical Engineering Nanyang Technological University 62 Nanyang Drive 637459 , Singapore Nanomedicine is one of the most promising areas in science and technology, leading to the convergence of nanotechnology and medicine towards improved diagnostic and therapeutic strategies that take advantage of the unique properties of materials at the nanoscale. Rapid developments in this fi eld are taking place in terms of both our scientifi c understanding of applied nanoscience as well as the engineering design of programmable nanotechnology platforms with tunable and desirable features. While the earliest accomplishments in nanomedicine principally focused on cancer medicine, there has been a recent explosion on new frontiers of clinical application, including neuroscience and infectious diseases. Shifting beyond classical examples of nanomedicines, we are also witnessing a greater diversity in relevant topics and applications as the lines between nanotechnology and medicine blur and lead to new innovations: platform technologies which redefi ne our vision of what nanomedicine is and what it can become.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here